Literature DB >> 20664647

Preempting and preventing drug-induced liver injury.

Guruprasad P Aithal, Ann K Daly.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20664647     DOI： 10.1038/ng0810-650

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  14 in total

1.  Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

Authors:  Michael E Farkouh; Howard Kirshner; Robert A Harrington; Sean Ruland; Freek W A Verheugt; Thomas J Schnitzer; Gerd R Burmester; Eduardo Mysler; Marc C Hochberg; Michael Doherty; Elena Ehrsam; Xavier Gitton; Gerhard Krammer; Bernhard Mellein; Alberto Gimona; Patrice Matchaba; Christopher J Hawkey; James H Chesebro
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

2.  Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis.

Authors:  A Kindmark; A Jawaid; C G Harbron; B J Barratt; O F Bengtsson; T B Andersson; S Carlsson; K E Cederbrant; N J Gibson; M Armstrong; M E Lagerström-Fermér; A Dellsén; E M Brown; M Thornton; C Dukes; S C Jenkins; M A Firth; G O Harrod; T H Pinel; S M E Billing-Clason; L R Cardon; R E March
Journal:  Pharmacogenomics J       Date:  2007-05-15       Impact factor: 3.550

3.  HLA association of amoxicillin-clavulanate--induced hepatitis.

Authors:  M L Hautekeete; Y Horsmans; C Van Waeyenberge; C Demanet; J Henrion; L Verbist; R Brenard; C Sempoux; P P Michielsen; P S Yap; J Rahier; A P Geubel
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

4.  A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience.

Authors:  Lawrence Goldkind; Loren Laine
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-04       Impact factor: 2.890

5.  Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.

Authors:  Giuseppe Traversa; Clara Bianchi; Roberto Da Cas; Iosief Abraha; Francesca Menniti-Ippolito; Mauro Venegoni
Journal:  BMJ       Date:  2003-07-05

6.  Acute and clinically relevant drug-induced liver injury: a population based case-control study.

Authors:  Francisco J de Abajo; Dolores Montero; Mariano Madurga; Luis A García Rodríguez
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

Review 7.  Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.

Authors:  Guruprasad P Aithal; Christopher P Day
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

8.  HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Authors:  Ann K Daly; Peter T Donaldson; Pallav Bhatnagar; Yufeng Shen; Itsik Pe'er; Aris Floratos; Mark J Daly; David B Goldstein; Sally John; Matthew R Nelson; Julia Graham; B Kevin Park; John F Dillon; William Bernal; Heather J Cordell; Munir Pirmohamed; Guruprasad P Aithal; Christopher P Day
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

9.  HLA-B*5701 screening for hypersensitivity to abacavir.

Authors:  Simon Mallal; Elizabeth Phillips; Giampiero Carosi; Jean-Michel Molina; Cassy Workman; Janez Tomazic; Eva Jägel-Guedes; Sorin Rugina; Oleg Kozyrev; Juan Flores Cid; Phillip Hay; David Nolan; Sara Hughes; Arlene Hughes; Susanna Ryan; Nicholas Fitch; Daren Thorborn; Alastair Benbow
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

Review 10.  Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs.

Authors:  J H Rubenstein; L Laine
Journal:  Aliment Pharmacol Ther       Date:  2004-08-15       Impact factor: 8.171
View more
  5 in total

Review 1.  Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.

Authors:  Vidyasagar Ramappa; Guruprasad P Aithal
Journal:  J Clin Exp Hepatol       Date:  2012-12-20

Review 2.  Hepatotoxicity related to antirheumatic drugs.

Authors:  Guruprasad P Aithal
Journal:  Nat Rev Rheumatol       Date:  2011-01-25       Impact factor: 20.543

Review 3.  Pharmacogenomics in clinical practice and drug development.

Authors:  Andrew R Harper; Eric J Topol
Journal:  Nat Biotechnol       Date:  2012-11-08       Impact factor: 54.908

Review 4.  Drug-induced liver injury: recent advances in diagnosis and risk assessment.

Authors:  Gerd A Kullak-Ublick; Raul J Andrade; Michael Merz; Peter End; Andreas Benesic; Alexander L Gerbes; Guruprasad P Aithal
Journal:  Gut       Date:  2017-03-23       Impact factor: 23.059

5.  Phenotype standardization for statin-induced myotoxicity.

Authors:  A Alfirevic; D Neely; J Armitage; H Chinoy; R G Cooper; R Laaksonen; D F Carr; K M Bloch; J Fahy; A Hanson; Q-Y Yue; M Wadelius; A H Maitland-van Der Zee; D Voora; B M Psaty; C N A Palmer; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2014-06-04       Impact factor: 6.875
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.